COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1001.5 | 1 | 0074-0155 | 282.20 | 154.87 | 260 | 62.18 | 0.845 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 10558.2 | 1 | 0075-0157 | 632.64 | 157.02 | 313 | 76.43 | 0.673 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2126.0 | 1 | 0076-0158 | 153.69 | 157.45 | 204 | 55.70 | 0.826 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 4175.8 | 1 | 0077-0163 | 328.00 | 163.42 | 260 | 61.01 | 0.878 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1906.6 | 1 | 0078-0163 | 125.94 | 162.81 | 221 | 58.77 | 0.804 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1974.0 | 1 | 0079-0165 | 582.66 | 164.81 | 259 | 59.01 | 0.935 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2080.2 | 1 | 0080-0168 | 806.15 | 168.59 | 186 | 50.28 | 0.924 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1251.4 | 1 | 0081-0173 | 353.97 | 173.37 | 375 | 73.01 | 0.884 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3007.7 | 1 | 0082-0176 | 393.44 | 175.46 | 308 | 66.77 | 0.868 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 5605.3 | 1 | 0083-0181 | 81.01 | 179.70 | 679 | 108.81 | 0.721 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1552.7 | 1 | 0084-0181 | 37.82 | 180.94 | 317 | 68.67 | 0.845 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2171.0 | 1 | 0085-0183 | 495.13 | 183.84 | 242 | 61.11 | 0.814 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2197.1 | 1 | 0086-0186 | 183.20 | 185.11 | 281 | 70.77 | 0.705 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1274.1 | 1 | 0087-0183 | 529.17 | 183.34 | 292 | 66.77 | 0.823 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 11532.6 | 1 | 0088-0188 | 592.87 | 187.56 | 324 | 71.26 | 0.802 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1727.4 | 1 | 0089-0188 | 151.31 | 188.09 | 239 | 63.01 | 0.756 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1119.8 | 1 | 0090-0186 | 472.32 | 186.20 | 273 | 62.18 | 0.887 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 6821.3 | 1 | 0091-0190 | 645.42 | 190.40 | 355 | 72.77 | 0.842 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2650.6 | 1 | 0092-0189 | 740.53 | 189.40 | 262 | 61.11 | 0.882 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3994.8 | 1 | 0093-0189 | 916.61 | 189.99 | 213 | 55.94 | 0.855 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 3928.0 | 1 | 0094-0199 | 661.63 | 199.51 | 212 | 54.53 | 0.896 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1270.0 | 1 | 0095-0202 | 325.65 | 202.00 | 219 | 55.36 | 0.898 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1606.1 | 1 | 0096-0203 | 781.21 | 202.87 | 198 | 52.53 | 0.902 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 1971.6 | 1 | 0097-0207 | 126.70 | 206.94 | 259 | 64.43 | 0.784 |
COLO 858 | Vemurafenib | 0 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 2412.8 | 1 | 0098-0208 | 842.96 | 208.21 | 277 | 62.53 | 0.890 |